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The nuclear factor erythroid 2-related fac-
tor 2 (Nrf2) is best known for its role in
resistance to oxidant stress. In this issue
of EMBO Molecular Medicine, Nrf2-pro-
longed genetic activation is shown with
devastating effects on skin homeostasis.
The study provides novel molecular
insights into poison-induced chloracne
and metabolizing acquired dioxin-induced
skin hamartomas or MADISH.
See also: M Sch€afer et al (April 2014)
S kin helps insulate the body andprotect it from mechanical stress,excessive water loss, and pathogens.
Interestingly, many noxious substances
entering the body through the skin or even
systemically are metabolized at least partly
in keratinocytes. Not surprisingly, poisoning
is often associated with skin lesions and
diverse skin reactions.
In this context, chloracne is one of the
most sensitive biological indicators of occu-
pational or environmental exposure to cer-
tain highly toxic halogenated aromatic
hydrocarbons. Such substances are often
trace contaminants produced during the syn-
thesis of industrial chemicals, such as herbi-
cides. Because low concentrations of dioxins
are widely distributed throughout the envi-
ronment and are both persistent and bioac-
cumulated, millions of people are exposed to
dioxin and dioxin-like compounds, primarily
through contaminated food. Poison-induced
chloracne appears regardless of whether
chemical exposure has occurred via skin
contact, inhalation, or ingestion. One of
the most potent inducers of chloracne is
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD),
and chloracne is the only skin disorder con-
sistently reported to be associated specifi-
cally with TCDD and other herbicides (Ma,
2013). The clinical features of chloracne
include multiple closed comedones that
evolve into deep cysts. As toxicity increases,
the posterior neck, trunk, and extremities
may be involved, while palms and soles,
which have no sebaceous glands (SGs), are
spared. Thus, based on clinical findings
alone, it can be difficult for physicians to dif-
ferentiate chloracne from some forms of
acne vulgaris. TCDD became notorious as a
contaminant of Agent Orange, an herbicide
used during the Vietnam War. More
recently, much was learned about TCDD
lesions from the 2004 assassination attempt
of the 3rd president of the Ukraine, Viktor
Yushchenko. He was poisoned by exposure
to TCDD at a single oral dose that was 5 million-
fold greater than the accepted daily
exposure limit. Yushchenko’s skin lesions
included hamartomas with a complete invo-
lution of SGs and cysts (Saurat et al, 2012).
These lesions were called “metabolizing
acquired dioxin-induced skin hamartomas”
(MADISH). These hamartomas accumulate
TCDD and express high levels of the TCDD-
metabolizing enzyme cytochrome P450 1A1;
thus, they represent a detoxification struc-
ture that is thought to reduce the systemic
toxicity of TCDD. TCDD affects keratinocyte
differentiation in vitro (Sutter et al, 2011),
and TCDD-mediated reactive oxygen species
(ROS) production is a critical step in TCDD-
accelerated keratinocyte differentiation
(Kennedy et al, 2013). TCDD also induces
changes in the pilosebaceous unit: The epi-
dermis and infundibulum undergo promi-
nent hyperplasia and hyperkeratosis, while
SGs and sweat glands become dysfunctional
and are replaced by keratinizing cells, result-
ing in cyst/hamartoma formation (Ju et al,
2009; Saurat et al, 2012).
......................................................
“This strongly resembles the
pathology of patients with
chloracne/MADISH at both the
histological and molecular
levels.”
......................................................
The work by Sch€afer et al (2014), pub-
lished in this issue of EMBO Molecular Med-
icine, offers novel insights into the
molecular basis of MADISH. It shows that
prolonged genetic activation of the nuclear
factor erythroid 2-related factor 2 (Nrf2) in
keratinocytes has a devastating impact on
skin homeostasis and leads to abnormalities
in the pilosebaceous unit. This was unex-
pected because a major function of Nrf2 is
its role in resistance to oxidant stress. Nrf2
is a transcription factor that senses radia-
tion- and chemical-induced oxidative and
electrophilic stresses; it controls a battery
of defensive genes encoding antioxidant
proteins and detoxifying enzymes, such as
NAD(P)H:quinone oxidoreductase 1 (NQO1)
and glutathione-S-transferases. Accordingly,
Nrf2-null mice show increased susceptibil-
ity to a broad range of chemical toxicities
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and to disease conditions associated with
oxidative pathology, while pharmacological
activation of Nrf2 by chemoprotective
agents protects against oxidative damage
(Ma, 2013). However, Nrf2 may also pro-
tect cancer cells from chemotherapeutic
drugs and thereby facilitate tumor cell
survival (Jaramillo & Zhang, 2013).
In the study by Sch€afer et al (2014), kerat-
inocyte-specific expression of constitutively
active Nrf2 in mice led to SG enlargement
and seborrhea with hyperkeratosis and
acanthosis of the hair follicle infundibuli and
interfollicular epidermis, thus replicating
some characteristics of non-inflammatory
acne in humans. As these mice aged, they
exhibited a MADISH phenotype character-
ized by the dilatation of infundibuli and
developed larger keratinized skin cysts com-
bined with the loss of SGs. This strongly
resembles the pathology of patients with
chloracne/MADISH at both the histological
and molecular levels. This phenotype was
initiated by upregulation of epigen (Epgn), a
growth factor and EGFR ligand that was
identified in the study as an Nrf2 target. Epgn
is expressed in undifferentiated sebocytes,
and Epgn transgenic mice develop enlarged
SGs due to expansion of basal, undifferenti-
ated cells in the gland in response to Epgn
overexpression (Dahlhoff et al, 2010). SG
enlargement was accompanied by increased
expression of the nuclear receptor peroxisome
proliferator-activated receptor c (PPARc)
(Sch€afer et al, 2014), which is important for
sebocyte differentiation and stimulation of a
subset of lipogenic genes for lipid storage in
these cells (Dozsa et al, 2013).
The study also identified previously
unknown functions of two Nrf2 target genes
that encode the secretory leukocyte pepti-
dase inhibitor (Slpi) and small proline-rich
protein 2 (Sprr2d) in the pilosebaceous unit.
These two proteins contribute to the ROS-
protective and anti-inflammatory activities
of Nrf2 because Sprrs are potent scavengers
of ROS and Slpi has antimicrobial activities
(Sch€afer et al, 2012). However, prolonged
Nrf2-induced overexpression of these two
proteins led to infundibulum acanthosis and
hyperkeratosis and ultimately to cyst forma-
tion. It also caused corneocyte fragility and
impaired desquamation and, consequently,
to alterations in the epidermal lipid barrier,
inflammation, and overexpression of mito-
gens that induce keratinocyte hyperprolifera-
tion (Sch€afer et al, 2012, 2014). Clinically,
these observations suggest a novel function
of NRF2 and its targets SPRR2D and SLPI in
MADISH pathogenesis.
Guided by the MADISH-like phenotype
observed in their Nrf2 transgenic mice,
Sch€afer et al (2014) treated human keratino-
cytes, which are the cells in MADISH
patients that are responsible for cyst forma-
tion, with TCDD. This resulted in upregula-
tion of NRF2 and its targets SPRR2D, SLPI,
and EPGN via activation of the aryl hydro-
carbon receptor (AHR, TCDD receptor),
which in turn stimulated its target genes
CYP1A1 and CYP1B1. Both AHR and NRF2
are required for the TCDD-mediated activa-
tion of SPRR2D, SLPI, and EPGN, revealing a
novel AHR-NRF2 signaling axis in keratino-
cytes (Fig 1). Supporting the idea that the
Nrf2 transgenic mouse is a clinically rele-
vant model for human MADISH-like skin
disease, Sch€afer et al (2014) also detected
strong expression of SPRR2D, SLPI, EPGN,
and the classical NRF2 target, NQO1, in the
epidermis and cysts epithelium of MADISH
patients. Together, these novel data provide
insights into the molecular events that
occur in keratinocytes after TCDD and unveil
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Figure 1. Schematic model of the Nrf2 and Ahr signaling pathways. In the absence of stress, Nrf2 forms
an inactive complex with Keap1, which is sequestered in the cytoplasm. Oxidative or electrophilic stress causes
this complex to interact with regulatory proteins, while post-translational modifications can result in
dissociation of Nrf2 from Keap1. Free Nrf2 migrates to the nucleus where it interacts with a small Maf protein to
form a complex that transactivates target genes that encode antioxidant and cytoprotective proteins. In hair
follicle infundibuli, Nrf2 activation stimulates Epigen, Sprr2d, and Slpi. Epgn stimulates proliferation of
infundibular keratinocytes via EGFR signaling, while Sprr2d upregulation weakens the epidermal barrier. The
latter leads to inflammation and enhanced keratinocyte proliferation that results in SG enlargement and
acanthosis. Slpi upregulation leads to decreased desquamation, which contributes to hyperkeratosis. Nrf2
signaling is also frequently increased in cancer following events such as mutation of Nrf2 and Keap1, protein–
protein interactions with Keap1, and low Keap1 expression. This increases nuclear Nrf2 levels and thus its
transcriptional activity. The involvement of Epgn in cancer is not well understood. When the dioxin receptor Ahr
is activated, it stimulates the expression of detoxifying genes such as Cyp1A1 and functionally interacts with
Nrf2 to enhance its signaling. In MADISH, it is thought that Nrf2 and Ahr cooperate to ameliorate dioxin
detoxification. AHR activates Nrf2 transcription and vice versa in other cell types.
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a novel TCCD-AHR-NRF2-SPRR2/SLPI/EPGN
axis in the pathogenesis of MADISH.
The early molecular events that initiate the
MADISH pathogenesis are not well under-
stood, which would require analysis of the
epidermis from patients exposed to chloracne-
gens at an early stage. Such biological sam-
ples are not readily available, since patients
only present for treatment when their symp-
toms appear. At this stage, the observable
alterations are secondary to the initial
changes. Further, the early events that occur
in human skin cannot be studied in TCDD-
treated mice because they do not develop a
skin hamartoma phenotype, possibly because
TCDD is metabolized differently in rodents
than in humans or because the biological
response to TCDD differs in the two.
......................................................
“Clinically, these observations
suggest a novel function of
NRF2 and its targets SPRR2D
and SLPI in MADISH patho-
genesis.”
......................................................
Nrf2 signaling is complex (Fig 1). Under
basal conditions, Nrf2 is associated with
Keap1, which brings Nrf2 into the Keap1-
Cul3-E3 ubiquitin ligase and results in Nrf2
degradation. Oxidative stress and electro-
philes weaken the Nrf2-Keap1 complex, and
Nrf2 accumulates in the nucleus, where it
dimerizes with members of the small Maf
family transcription factors and binds to
antioxidant response elements (AREs)
within the regulatory regions of a wide vari-
ety of target genes (Jaramillo & Zhang,
2013). Furthermore, the Nrf2-Keap1 com-
plex is controlled by its crosstalk with other
proteins, such as the substrate adaptor
sequestosome 1 protein, cyclin-dependent
kinase inhibitor 1, and dipeptidyl peptidase
3. It is unknown whether these interactions,
which occur in cancer cells, also control
Nrf2 activity in keratinocytes during
MADISH pathogenesis and whether they are
controlled by TCDD-AHR signaling.
While it is tempting to propose that Nrf2
and/or the Nrf2-Keap1 complex are poten-
tial targets for therapeutics that reduce MA-
DISH progression, such Nrf2-based drugs
will likely impede TCDD detoxification in
situations in which it would be preferable
to activate Nrf2 to increase detoxification.
These questions require further investiga-
tion, precluding a simple conclusion
about the role of Nrf2 in the etiology of
chloracne.
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